Epitinib

Epitinib is a brain-penetrant, selective EGFR tyrosine kinase inhibitor suitable for oral administration. It is used in preclinical research to investigate EGFR-driven cancers, particularly in models of brain metastases and glioblastoma, through both in vitro and in vivo studies.